March 2023 – Biocartis, Inc. received FDA approval to market their IdyllaTM MSI test. The IdyllaTM MSI test is a fully automated test, producing results in less than three hours. Unique to most other MSI test kits on the market, matched normal tissue is not needed and formalin-fixed, paraffin-embedded (FFPE) colorectal cancer tissue sections are […]
July 2021 – Promega, Corp. received FDA approval for the clinical use of their OncoMate® MSI DX Analysis System to determine microsatellite instability (MSI) in colorectal cancer tumors. This is the first FDA-approved PCR-based diagnostic MSI characterization kit for clinical use in the U.S. Their new multiplex MSI assay utilizes novel long mononucleotide repeat markers […]
March 2024 – Recent research suggests that DNA damage caused by gut bacteria may be a key factor in the rising rates of young-onset bowel cancer. Bowel cancer, the most common cause of cancer-related death in people aged 20 to 39, has seen a doubling of rates in this age group over the past two […]
April 2023 – AACR Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research awarded to Polly A. Newcomb, PhD, MPH For tireless support of cancer education and training, highlighted by her many years of mentorship and encouragement of countless graduate students, postdoctoral fellows, and early-stage investigators, including underrepresented minority […]
July 2023 – We have created a website that reflects what the CCFR is today to facilitate a stronger connection with our research community. We hope the fresh look and improved navigation allows you to get to know our valued participants, keep up to date with our latest news and events. Thanks to everyone who has helped […]
May 2023 – In response to the renewal grant application submitted to U.S. National Cancer Institute (NCI) in March 2022, top leadership at the NCI awarded the CCFR with 5 additional years of funding, through April 2028. In their grant application, they proposed: The CCFR wishes to thank their 42,500 study participants for their many […]
May 2023 – A recent analysis has found the strongest evidence to date, that people with a high body mass index (a measure of weight for people of equal height) are more likely to develop colorectal cancer. For people of the same height, a 5kg increase in weight was associated with an 18% rise in […]